By
Shaoyu Chang, MD, MPH, Director of Research & Asia Business Development Liaison, LSN
The third RESI San Francisco Conference event, held on January 10th, saw 30 Innovation Challenge finalists competing for the votes of the largest RESI crowd to date. With 1,000 attendees present, more votes were cast than in any Innovation Challenge to date. Biotech, medical device, diagnostic and digital health companies all competed in the exhibition-style challenge for the top prize. Selected from over 100 applicants, the 30 finalists included many phenomenal startups. Here, LSN would like to present the 3 winners.
First Place: Pathcore (Toronto, Canada)
Second Place: Myndblue (Cambridge, MA)
Third Place: Propep Surgical (Austin, TX)
Thank you to all who competed in the RESI San Francisco Innovation Challenge, and to all the RESI attendees who took part by investing their votes in their favorite competing companies.
Life Science Investor Mandates
The third RESI San Francisco Conference event, held on January 10th, saw 30 Innovation Challenge finalists competing for the votes of the largest RESI crowd to date. With 1,000 attendees present, more votes were cast than in any Innovation Challenge to date. Biotech, medical device, diagnostic and digital health companies all competed in the exhibition-style challenge for the top prize. Selected from over 100 applicants, the 30 finalists included many phenomenal startups. Here, LSN would like to present the 3 winners.
